๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan ยท Delayed Price ยท Currency is JPY
1,895.50
+2.00 (0.11%)
Nov 20, 2026, 9:04 AM JST

Sumitomo Pharma Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
492,662453,294398,832314,558555,544560,035
Revenue Growth
10.66%13.66%26.79%-43.38%-0.80%8.54%
Gross Profit
262,437256,893245,502187,981376,625402,908
Operating Income
-1,76952,80117,770-355,136-126,34959,967
Net Income
46,243106,86523,634-314,969-74,51256,413
Earnings Per Share
110.18268.9959.49-792.79-187.55141.99
EPS Growth
-71.71%352.17%---0.34%

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
Pharmaceuticals - North America
337,923251,814159,037328,467319,790
Pharmaceuticals - Japan
92,36599,838114,657126,164149,976
Pharmaceuticals - Asia
23,00647,18040,864--
Total
453,294398,832314,558555,544560,035

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
77,75944,31036,28829,047143,478202,984
Total Debt
139,692224,216314,246427,864346,372284,544
Net Cash (Debt)
-61,933-179,906-277,958-398,817-202,894-81,560
Net Cash Growth
------
Net Cash Per Share
-147.56-452.83-699.64-1003.84-510.69-205.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
70,36371,71516,500-241,89311,93731,239
Capital Expenditures
-2,826-4,609-8,498-10,771-8,467-7,347
Free Cash Flow
67,53767,1068,002-252,6643,47023,892
Free Cash Flow Growth
193.41%738.62%---85.48%-81.56%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
53.27%56.67%61.56%59.76%67.79%71.94%
Operating Margin
-0.36%11.65%4.46%-112.90%-22.74%10.71%
Pretax Margin
9.52%22.14%4.42%-102.72%-8.63%14.81%
Profit Margin
9.39%23.57%5.93%-100.13%-13.41%10.07%
FCF Margin
13.71%14.80%2.01%-80.32%0.63%4.27%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
15.000---21.00028.000
Dividend Per Share Growth
0%----25.00%0%
Dividend Yield
0.79%---2.59%2.32%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
17.207.7212.26--8.51
Forward PE
9.209.4519.1620.7320.7311.10
P/FCF Ratio
12.5912.2936.19-92.7420.09
PS Ratio
1.731.820.730.500.580.86